WallStreetZenWallStreetZen

NASDAQ: ARDS
Aridis Pharmaceuticals Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

ARDS past revenue growth

How has ARDS's revenue growth performed historically?
Company
422.81%
Industry
61.56%
Market
21.8%
ARDS's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
ARDS's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
ARDS's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

ARDS earnings and revenue history

Current Revenue
$2.9M
Current Earnings
-$32.8M
Current Profit Margin
-1,144.6%

ARDS Return on Equity

Current Company
N/A
Current Industry
-9.8%
Current Market
-9.5%

Be the first to know when ARDS announces earnings.

ARDS Return on Assets

Current Company
-165.2%
Current Industry
0.6%
ARDS is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

ARDS Return on Capital Employed

Current Company
107.05%
Current Industry
11.2%
ARDS has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ARDS vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
ARDS$2.87M-$31.74M-$32.79M+7.33%N/A
ADXN$1.24M-$21.32M-$21.79M-35.55%N/A
CYCC$0.00-$25.88M-$21.40M-100.00%N/A
PBLA$0.00-$34.76M-$34.93MN/AN/A
CMND$0.00N/A-$9.81MN/AN/A
View Top Biotech Stocks

ARDS earnings dates

Next earnings date
Mar 29, 2023

Aridis Pharmaceuticals Earnings & Revenue FAQ

What were ARDS's earnings last quarter?

On Invalid Date, Aridis Pharmaceuticals (NASDAQ: ARDS) reported Q3 2022 earnings per share (EPS) of -$0.47, up 75.77% year over year. Total Aridis Pharmaceuticals earnings for the quarter were -$8.24 million. In the same quarter last year, Aridis Pharmaceuticals's earnings per share (EPS) was -$1.94.

If you're new to stock investing, here's how to buy Aridis Pharmaceuticals stock.

What was ARDS's earnings growth in the past year?

As of Q1 2023, Aridis Pharmaceuticals's earnings has grown year over year. Aridis Pharmaceuticals's earnings in the past year totalled -$32.79 million.

What is ARDS's earnings date?

Aridis Pharmaceuticals's earnings date is Invalid Date. Add ARDS to your watchlist to be reminded of ARDS's next earnings announcement.

What was ARDS's revenue last quarter?

On Invalid Date, Aridis Pharmaceuticals (NASDAQ: ARDS) reported Q3 2022 revenue of $399.00 thousand up 22.52% year over year. In the same quarter last year, Aridis Pharmaceuticals's revenue was $515.00 thousand.

What was ARDS's revenue growth in the past year?

As of Q1 2023, Aridis Pharmaceuticals's revenue has grown 422.81% year over year. This is 361.26 percentage points higher than the US Biotechnology industry revenue growth rate of 61.56%. Aridis Pharmaceuticals's revenue in the past year totalled $2.87 million.
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTube
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.